Clinical trial
Effect of Intravenous Infusion of Esketamine Combined Pulsed Radiofrequency on Acute/Subacute Zoster-associated Trigeminal Neuralgia
NCT06890897 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Intravenous Infusion of Esketamine Combined Pulsed Radiofrequency on Acute/Subacute Zoster-associated Trigeminal Neuralgia
- Lead sponsor
- Beijing Tiantan Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 1, 2025
- Completion date
- September 30, 2026
- Enrollment
- 174 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
zoster; herpes, trigeminal neuralgia (etiology)